Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN SEPRASE) (HUMAN MONOCLONAL FAP-IL-2V HEAVY CHAIN) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER) FUSION PROTEIN WITH INTERLEUKIN 2 (HUMAN MUTANT QM IL-2), DISULFIDE WITH HUMAN MONOCLONAL FAP-IL-2V LIGHT CHAIN, DIMER WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN SEPRASE) (HUMAN MONOCLONAL FAP-IL-2V HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL FAP-IL-2V LIGHT CHAIN

Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers

Hoffmann-La Rochemonoclonal_antibodyPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers cohort.

Asset / SponsorPhaseRating
Atezolizumab
Hoffmann-La Roche
Phase 2CCC
Vinorelbine
Hoffmann-La Roche
Phase 2CCC

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN SEPRASE) (HUMAN MONOCLONAL FAP-IL-2V HEAVY CHAIN) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER) FUSION PROTEIN WITH INTERLEUKIN 2 (HUMAN MUTANT QM IL-2), DISULFIDE WITH HUMAN MONOCLONAL FAP-IL-2V LIGHT CHAIN, DIMER WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN SEPRASE) (HUMAN MONOCLONAL FAP-IL-2V HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL FAP-IL-2V LIGHT CHAIN is also rated in:

head and neck cancerDormant
CC
Indicative ·
47 / 100
View asset →
pancreatic adenocarcinomaDormant
CC
Indicative ·
46 / 100
View asset →
metastatic melanomaDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →